Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 2 ACEI/ARB type by disposition

From: Disposition of emergency department patients presenting with angiotensin-converting enzyme inhibitor-induced angioedema

Agent

Number (% of total patients)

ICU Admit (% of drug group)

Floor Admit (% of drug group)

Sent Home (% of drug group)

Lisinopril

74 (78.7)

15 (27.3)

25 (33.8)

34 (45.9)

Benazepril

10 (10.64)

2 (20)

3 (30)

5 (50)

Losartan

3 (3.19)

0

3 (100)

0

Ramipril

3 (3.19)

1 (33.3)

0

2 (66.7)

Valsartan

1 (1.06)

1 (100)

0

0

Enalapril

1 (1.06)

0

1 (100)

0

Fosinopril

1 (1.06)

0

0

1 (100)

Quinopril

1 (1.06)

0

0

1 (100)

Totals

Total Group

Total ICU Admissions (% of total)

Total Floor Admissions (% of total)

Total ED Discharges (% of total)

Study Totals

94

19 (20.2)

32 (34.1)

43 (45.7)